Ginkgo Results Presentation Deck

We believe... 1 Zymergen and Bayer will improve our platform and drive better customer outcomes The pending additions of Zymergen and Bayer's ag biologicals assets are expected to meaningfully benefit our platform and customers, adding both entirely new capabilitie as well as driving system-wide improvements 2 We remain focused on our cash runway and achieving profitability We are focused on maintaining our multi-year cash runway and driving toward long-term profitability. In addition to general fiscal discipline, our business model affords several levers we can pull, including scale economics on the platform as well as the types of programs we take on 3 Sustainability is fundamental to our strategy ESG is not window dressing for Ginkgo, it's in our DNA. We believe our framework of care has enabled us to take advantage of key strategic opportunities while furthering o mission and is critical to our long-term sustainable performance 15 Property of Ginkgo Bioworks Q2 2022 UPDATE & BUSINESS REVIEW

View entire presentation